Insider · CIK 0001831125
Stephen D. Griffin
cfoofficercoo
Files at ANIK (Anika Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | ANIK Anika Therapeutics, Inc. | MOption exercise Common Stock | +12,840 | $0.00 | $0 | 13,640 | Jun 5, 2025 |
| Jun 3, 2025 | ANIK Anika Therapeutics, Inc. | FTax withholding Common Stock | -3,769 | $11.59 | $44k | 9,871 | Jun 5, 2025 |
| Jun 3, 2025 | ANIK Anika Therapeutics, Inc. | MOption exercise Restricted Stock Unitderivative | +12,840 | $0.00 | $0 | 25,680 | Jun 5, 2025 |
| Mar 14, 2025 | ANIK Anika Therapeutics, Inc. | AGrant or award Restricted Stock Unitderivative | +38,473 | $0.00 | $0 | 38,473 | Mar 18, 2025 |
| Mar 14, 2025 | ANIK Anika Therapeutics, Inc. | AGrant or award Restricted Stock Unitderivative | +18,672 | $0.00 | $0 | 18,672 | Mar 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.